Literature DB >> 21395630

Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.

R S Choung1, K C Ruff, A Malhotra, L Herrick, G R Locke, W S Harmsen, A R Zinsmeister, N J Talley, Y A Saito.   

Abstract

BACKGROUND: There has been increasing interest in small intestinal bacterial overgrowth (SIBO) after reports of a link with irritable bowel syndrome (IBS), yet our understanding of this entity is limited. AIM: Our aim was to estimate the yield of patients undergoing duodenal aspirate culture, and to identify symptoms and features that predict SIBO.
METHODS: A medical chart review of patients who had undergone duodenal aspirate culture at an academic medical centre in 2003 was performed to record clinical characteristics and culture results. The associations between aspirate results and symptoms, medical diagnoses and medication use were assessed using logistic regression.
RESULTS: A total of 675 patients had available aspirate results. Mean age of the sample was 53 (s.d. 17) and 443 (66%) were female patients. Overall, 8% of aspirates were positive for SIBO; 2% of IBS patients had SIBO. Older age, steatorrhoea and narcotic use were associated with SIBO (P < 0.05). PPI use was not associated with SIBO, but was associated with bacterial growth not meeting criteria for SIBO (P < 0.05). Inflammatory bowel disease (IBD), small bowel diverticula and pancreatitis were positively associated with an abnormal duodenal aspirate (P < 0.05), but other conditions including IBS were not associated with SIBO.
CONCLUSION: Older age, steatorrhoea, narcotic use, IBD, small bowel diverticula and pancreatitis were associated with small intestinal bacterial overgrowth based on abnormal duodenal aspirate culture results. However, no clear associations of true small intestinal bacterial overgrowth with IBS or PPI use were detected, in contrast to recent speculation.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21395630     DOI: 10.1111/j.1365-2036.2011.04625.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  38 in total

Review 1.  Microbiota: a novel regulator of pain.

Authors:  Manon Defaye; Sandie Gervason; Christophe Altier; Jean-Yves Berthon; Denis Ardid; Edith Filaire; Frédéric Antonio Carvalho
Journal:  J Neural Transm (Vienna)       Date:  2019-09-24       Impact factor: 3.575

Review 2.  Gastroduodenal "Dysbiosis": a New Clinical Entity.

Authors:  Ayesha Shah; Mark Morrison; Gerald J Holtmann
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

3.  Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air?

Authors:  Brian E Lacy; Scott L Gabbard; Michael D Crowell
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

Review 4.  Endoscopic and Conservative Management of Chronic Pancreatitis and Its Complications.

Authors:  Alexander Waldthaler; Roberto Valente; Urban Arnelo; J-Matthias Löhr
Journal:  Visc Med       Date:  2019-04-03

5.  Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: a retrospective study of 932 patients.

Authors:  Richard A Schatz; Qing Zhang; Nilesh Lodhia; Jonathan Shuster; Phillip P Toskes; Baharak Moshiree
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

6.  Association Between Small Intestinal Bacterial Overgrowth by Glucose Breath Test and Coronary Artery Disease.

Authors:  Andre Fialho; Andrea Fialho; Gursimran Kochhar; Aldo L Schenone; Prashanti Thota; Arthur J McCullough; Bo Shen
Journal:  Dig Dis Sci       Date:  2017-11-06       Impact factor: 3.199

Review 7.  Overgrowth of the indigenous gut microbiome and irritable bowel syndrome.

Authors:  William Bye; Naveed Ishaq; Terry D Bolin; Vic M Duncombe; Stephen M Riordan
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

8.  Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth.

Authors:  C Jacobs; E Coss Adame; A Attaluri; J Valestin; S S C Rao
Journal:  Aliment Pharmacol Ther       Date:  2013-04-10       Impact factor: 8.171

9.  The alterations of gut microbiota in mice with chronic pancreatitis.

Authors:  Man-Man Han; Xiang-Yun Zhu; You-Fan Peng; Hao Lin; De-Chen Liu; Ling Li
Journal:  Ann Transl Med       Date:  2019-09

10.  Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study.

Authors:  Daniel Keszthelyi; Gwen H Dackus; Gwen M Masclee; Joanna W Kruimel; Ad A M Masclee
Journal:  BMC Gastroenterol       Date:  2012-09-05       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.